This inventor holds 1 USPTO granted patent. Top assignee: Novimmune Sa. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Christina De Min: Innovator in TLR4 Research
Introduction
Christina De Min is a prominent inventor based in Geneva, Switzerland. She has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of disorders associated with elevated levels of Toll-like Receptor 4 (TLR4) ligands.
Latest Patents
Christina holds 1 patent for her invention titled "Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of TLR4 ligands and other biomarkers." This invention focuses on methods and compositions that aid in diagnosing and treating disorders linked to elevated TLR4 ligands. It also explores treatment methods that involve agents that interfere with TLR4 signaling, including neutralizing anti-TLR4 antibodies.
Career Highlights
Christina is currently associated with Novimmune SA, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of TLR4-related disorders and potential therapeutic approaches.
Collaborations
Some of her notable coworkers include Limin Shang and Emmanuel Monnet, who have collaborated with her on various research projects.
Conclusion
Christina De Min's innovative work in TLR4 research highlights her commitment to improving medical diagnostics and treatments. Her contributions are paving the way for advancements in understanding and managing disorders associated with TLR4 ligands.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile